Transcriptional control in hepatocyte proliferation

描述（由申请人提供）：肝脏从毒性、感染性或炎性损伤中恢复的能力以及肝移植后的恢复能力在很大程度上是由于静止（GO）、代谢活性肝细胞重新进入细胞周期的能力。肝细胞重新进入细胞周期和基因组完整性严重依赖于E2 F调节的DNA复制许可因子的激活。TGF-α在肝细胞癌的生理生长和癌前阶段诱导肝细胞增殖。我们已经确定了C/EBP？作为E2 F调节基因的关键转录激活因子，在肝细胞增殖期间控制DNA复制许可。我们已经证明，在原代肝细胞中，C/EBP <$依赖性DNA复制因子的诱导既受TGF-α刺激，又依赖于C/EBP <$。最近的证据已经确定了代谢状态和细胞周期相关基因的激活之间的重要联系，包括那些由E2 F因子调节的基因。我们已经发现，潜在的辅激活因子PGC-1a，以前牵连在响应禁食，被快速诱导后，部分肝切除术中的C/EBP <$-依赖性的方式，并结合到E2 F调节基因的启动子，包括几个C/EBP <$靶标，这表明该辅激活因子是代谢信号和肝细胞增殖之间的重要联系。基于我们实验室和其他实验室的数据，我们假设C/EBP是肝细胞生长因子和代谢信号的中心整合者。在具体目标1中，我们将研究C/EBP <$磷酸化和C/EBP <$-E2 F相互作用对肝细胞增殖过程中DNA许可蛋白调控的贡献。在具体目标2中，我们将研究C/EBP？激活PGC-1a的机制。在具体目标3中，我们将分析PGC-1a在再生肝脏中肝细胞增殖中的功能作用。此补助金申请是直接响应计划公告PA-06-231。“发育生物学和肝脏再生。“了解肝细胞增殖的潜在机制将为开发增强肝脏再生能力的治疗方法提供信息，并将阐明肝细胞癌变早期阶段发生的异常肝细胞增殖的机制。

DESCRIPTION (provided by applicant): The ability of the liver to recover from toxic, infectious or inflammatory injury and following liver transplantation is due in large part to the ability of quiescent (GO), metabolically active hepatocytes to reenter the cell cycle en masse. Hepatocyte reentry into the cell cycle and genomic integrity are critically dependent on E2F regulated activation of DNA replication licensing factors. TGF-a induces hepatocyte proliferation in physiologic growth and in the preneoplastic stages of hepatocellular carcinoma. We have identified C/EBP¿ as a key transcriptional activator of E2F-regulated genes that control the licensing of DNA replication during hepatocyte proliferation. We have shown that induction of C/EBP¿-dependent induction of DNA replication factors is both stimulated by TGF-a and dependent on C/EBP¿ in primary hepatocytes. Recent evidence has identified an important link between the metabolic state and activation of cell cycle associated genes including those regulated by E2F factors. We have discovered that the potential coactivator PGC-1a, previously implicated in the response to fasting, is rapidly induced following partial hepatectomy in a C/EBP¿-dependent manner and is bound to the promoters of E2F regulated genes including several C/EBP¿ targets, suggesting that this coactivator is an important link between metabolic signals and hepatocyte proliferation. Based on data from our laboratory and others, we hypothesize that C/EBP¿ is a central integrator of growth factor and metabolic signals to hepatocytes. In Specific Aim 1, we will investigate the contribution of C/EBP¿ phosphorylation and C/EBP¿-E2F interactions for regulation of DNA licensing proteins during hepatocyte proliferation. In Specific Aim 2, we will investigate the mechanism for activation of PGC-1a by C/EBP¿. In Specific Aim 3, we will analyze the functional role of PGC-1a in hepatocyte proliferation in the regenerating liver. This grant application is directly responsive to Program announcement PA-06-231. "Developmental Biology and Regeneration of the Liver." Understanding the mechanisms underlying hepatocyte proliferation will inform the development of therapeutics to augment the regenerative capacity of the liver and will elucidate mechanisms of abnormal hepatocyte proliferation that occur during early stages of hepatocellular carcinogenesis.